Your browser doesn't support javascript.
loading
Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma - an observational study.
Verkouteren, B J A; Oostewechel, L C F; Nelemans, P J; Sinx, K A E; Arits, A H M M; Vernemmen, A I P; Winnepenninckx, V J L; Kelleners-Smeets, N W J; Mosterd, K.
Affiliation
  • Verkouteren BJA; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Oostewechel LCF; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Nelemans PJ; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Sinx KAE; Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Arits AHMM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Vernemmen AIP; GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
  • Winnepenninckx VJL; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Kelleners-Smeets NWJ; Department of Dermatology, Catherina Hospital, Eindhoven, The Netherlands.
  • Mosterd K; Department of Pathology, Maastricht University, Maastricht, The Netherlands.
J Eur Acad Dermatol Venereol ; 36(6): e475-e477, 2022 06.
Article in En | MEDLINE | ID: mdl-35073428
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Basal Cell / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article